GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HEARTWARE (HTWR) [hlAlert]

Rating:
Buy HTWR
up 29.61 %

HEARTWARE (HTWR) rated Buy with price target $84 by Auriga U.S.A

Posted on: Friday,  Jun 25, 2010  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy HEARTWARE (NASDAQ: HTWR) on 06/25/2010, when the stock price was $71.00. Since then, HEARTWARE has gained
29.62% of its value until Auriga U.S.A rated HTWR Hold on 12/03/2010, when the price was $92.03.
If you would have followed this Auriga U.S.A's recommendation on HTWR, you would have gained 29.61% of your investment in 161 days.

HeartWare International, Inc. (HeartWare), formerly HeartWare Limited, along with its subsidiaries, is a medical device company focused on developing small implantable pumps for the treatment of advanced heart failure. The Company?s product, the HeartWare Ventricular Assist System (the HeartWare System), includes a left ventricular assist device (LVAD), related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The core of the HeartWare System is a continuous flow blood pump, ventricular assist device (the HVAD Pump), a full-output device capable of pumping up to 10 liters of blood per minute. In January 2009, the HeartWare System received Conformite Europeene (CE) Marking, which allows for commercial sales in Europe and is the subject of an ongoing United States bridge-to-transplant clinical trial under an investigational device exemption (IDE) granted by the Food and Drug Administration of United States (FDA).

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/11/2011 8:25 AM Hold
None
80.55 80.00
as of 12/31/2010
1 Week   
1 Month up  0.07 %
3 Months up  33.84 %
1 YTD up  29.61 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/11/2011 8:25 AM Buy
None
98.01 101.00
12/3/2010 8:25 AM Hold
None
92.03 97.00
6/25/2010 8:25 AM Buy
None
71.00 84.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy